Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol

Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol

Abstract Background Lipid-lowering therapy is guided by Low-density-lipoprotein cholesterol (LDL-c) levels, although the cardiovascular disease (CVD) risk could be better reflected by other lipid parameters. This study aimed at comparing a comprehensive lipid profile between patients with type 2 dia...

Full description

Bibliographic Details
Main Authors: Liliana Fonseca, Sílvia Paredes, Helena Ramos, José Carlos Oliveira, Isabel Palma
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Lipids in Health and Disease
Subjects:
Dyslipidemia
ApoB
LDL-c
CVD
CV risk
Non-HDL cholesterol
Online Access:http://link.springer.com/article/10.1186/s12944-020-01292-w

Internet

http://link.springer.com/article/10.1186/s12944-020-01292-w

Similar Items